Professor, Radiation Oncology, School of Medicine, University of Maryland
Radiation Oncology
Dr. Minesh P. Mehta, MD
|
|
Give Review
Minesh Mehta works in the field of Radiation Oncology. He has 3 awards "America's Top Doctors", "America's Top Doctors for Cancer" and "Top Doctors:Baltimore Area". Dr. Minesh P. Mehta is also a published doctor. He has 99 paper published. The most recent paper is: CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
Publications
- Proton Beam Therapy Basics.
- CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
- Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
- Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Childr...
- Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.
- Real-time pretreatment review limits unacceptable deviations on a cooperative group radiation therapy technique trial: quality assurance results of RTOG 0933.
- Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).
- Should we irradiate a brain tumor in a patient with parkinsonism? A case report and literature review.
- Dose escalation for GBM in the temozolamide era: in regard to Badiyan et al.
- Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Pha...
- Is proton beam therapy better than standard radiation therapy? The available evidence points to benefits of proton beam therapy.
- Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Meta...
- It is Time to Re-evaluate the Management of Patients with Brain Metastases.
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
- Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non-Small-Cell Lung Cancer.
- Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide...
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial.
- Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
- Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
- New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NC...
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
- In regard to sperduto et Al.
- RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma.
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
- American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
- Molecular profiling in non-small cell lung cancer: a step toward personalized medicine.
- Pseudoprogression after glioma therapy: a comprehensive review.
- The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.
- Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy.
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer ...
- Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
- Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer.
- A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
- Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Small Cell and Non-Small Cell Lung Carcinoma.
- RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients.
- A nomogram for individualized estimation of survival among patients with brain metastasis.
- Pro: lung cancer in 2011: a time for optimism and investment in new approaches and technologies with a commitment to produce evidence-based data.
- Brain metastases: what's new with an old problem?
- Reply to drs. Mulvenna and holt.
- An LXR agonist promotes GBM cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
- It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology.
- Myeloid Biomarkers Associated with Glioblastoma Response to Anti-Vascular Endothelial Growth Factor Therapy with Aflibercept.
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study.
- Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ? 6 brain meta...
- Intensity-Modulated Radiotherapy Might Increase Pneumonitis Risk Relative to Three-Dimensional Conformal Radiotherapy in Patients Receiving Combined Chemotherapy and R...
- Clinical trial end points for high-grade glioma: the evolving landscape.
- Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
- Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy.
- Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base co...
- Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?
- Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy: in regard to Song et al.
- Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.
- Current practices of driving restriction implementation for patients with brain tumors.
- Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma.
- Opportunities for clinical research in meningioma.
- Fractionated radiotherapy for intracranial meningiomas.
- Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.
- Angiogenic blockade and radiotherapy in hepatocellular carcinoma.
- A Comparison of Helical Tomotherapy to Circular Collimator-Based Linear-Accelerator Radiosurgery for the Treatment of Brain Metastases.
- Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium St...
- Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature.
- Stereotactic Body Radiation Therapy in Non-Small-Cell Lung Cancer: Linking Radiobiological Modeling and Clinical Outcome.
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.
- The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
- The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice gui...
- The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
- The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.
- The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.
- A multigene predictor of outcome in glioblastoma.
- The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
- On the estimation of the location of the hippocampus in the context of hippocampal avoidance whole brain radiotherapy treatment planning.
- Radiation techniques in neuro-oncology.
- The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.
- A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.
- Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases...
- Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.
- EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
- Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell l...
- Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.
- Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.
- Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
- Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thal...
- A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
- Radiation oncology advances: an introduction.
- Combined chemoradiotherapy advances.
- Megavoltage computed tomography: an emerging tool for image-guided radiotherapy.
- Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
- Advances in radiation therapy for brain tumors.
- Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.
- Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation.
- Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
- Targeted therapy for brain metastases: improving the therapeutic ratio.
- Radiation for brain metastases.
- Therapeutic advances in the treatment of brain metastases.
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
Education
-
University of Wisconsin
Hospital
-
Northwestern Memorial Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Anupama Thakrar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marina Kuznetsova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renuka Malik, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donthamsetti Seshagirirao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Hayes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Diana Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline J. Novak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paige L. Dorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alex Herskovic, MD |
|
|
Dr. Eric D. Donnelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Encouse Golden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neilayan Neilayan, MD |
|
|
Dr. Jagdish Thakrar, MD
This Doctor is OpenDoctor Recommended.
|